Medical Device News Magazine

Gastroenterology Group of Naples Announces the Introduction of Axonics Sacral Neuromodulation Therapy

New Treatment Option Offers Long-Term Relief for Those Suffering from Gastrointestinal Disorders

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Gastroenterology Group of Naples

Gastroenterology Group of Naples, a partner practice of United Digestive, is pleased to announce the introduction of Axonics Sacral Neuromodulation Therapy to its list of advanced treatment options for those suffering from fecal incontinence. This innovative therapy involves a minimally invasive outpatient procedure in which a device is implanted that helps to restore normal communication between the brain and bowel by gently stimulating nerves. This nerve stimulation can result in symptom improvement.
Dr. Rafael Urbina of the Gastroenterology Group of Naples explains that Axonics Therapy represents a significant advancement in the field of gastroenterology.

Axonics Therapy

“At Gastroenterology Group of Naples, we are committed to staying at the forefront of medical innovation to ensure that our patients receive the highest standard of care. Axonics Therapy represents a significant advancement in our field and heralds a new era in gastroenterology, offering patients a transformative alternative for managing certain specific gastrointestinal disorders.”

This new therapy provides an alternative solution for patients who have not found success with traditional treatments, as well as the potential for long-term relief and improved quality of life.

Dr. Rafael Urbina of the Gastroenterology Group of Naples

“This innovative approach provides hope and relief for those who have not found success with conventional treatments. Many patients with gastrointestinal disorders experience significant disruptions in their daily lives. We can now offer them a minimally invasive solution that can significantly improve their quality of life.”

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

ArisGlobal Reports | Newest Version of LifeSphere® Regulatory Platform Launches

Ann-Marie Orange, CIO & Global Head of R&D shares, “With more than 35 years of experience in life sciences technology, ArisGlobal is the only technology company offering strong Safety, Regulatory, and Quality Management solutions powered with next-generation cognitive computing, delivering unmatched interoperability across the R&D IT ecosystem. Over the last 18 months ArisGlobal has made significant investment in the strategic acquisitions of Amplexor Life Sciences and SPORIFY, along with technology R&D – and we’re not stopping.”